News and Events

Recombinant COVID-19 Virus Spike Proteins Available From LakePharma

LakePharma Update About the COVID-19 Pandemic – Being Part of the Solution

Webinar Recording Now Available: PentaMice™: A Unique Approach to Achieve Maximum Plasma Titers for Antibody Discovery

PentaMice™: A Unique Approach to Achieve Maximum Plasma Titers for Antibody Discovery

LakePharma and NJ Bio Form Strategic Alliance to Provide Streamlined Antibody-Drug Conjugate Services

LakePharma will manufacture and provide antibodies as starting materials for ADC development carried out by NJ Bio in a single, seamless workflow for clients, making therapeutic ADC manufacturing from initial antibody discovery to the production of the drug conjugates significantly more efficient both in time and expense.

LakePharma Announces Expansion into the Dallas/Fort Worth Metroplex

 LakePharma has opened a new office in Dallas, Texas. The new location allows LakePharma to better align its services with clients’ demands in the rapidly growing biologics industry.